📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment. (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgaa403

PubMed Identifier: 32617576

Publication URI: http://europepmc.org/abstract/MED/32617576

Type: Journal Article/Review

Volume: 106

Parent Publication: The Journal of clinical endocrinology and metabolism

Issue: 1

ISSN: 0021-972X